Myotonic Disorders
📧 Sign up to get email alerts when something new happens for Myotonic Disorders.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-03EMA Authorised: Namuscla (Mexiletine hydrochloride) — Lupin Europe GmbH
Namuscla (mexiletine hydrochloride) by Lupin Europe GmbH has been authorised for myotonic disorders in the EU.
-
EMA approval · 2026-01-16EMA Authorised: Namuscla (Mexiletine hydrochloride) — Lupin Europe GmbH
The European Medicines Agency authorised Namuscla (mexiletine hydrochloride) for myotonic disorders under Lupin Europe GmbH, with orphan des…